Correlation Between Emergent Biosolutions and Pacira BioSciences,
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Pacira BioSciences,, you can compare the effects of market volatilities on Emergent Biosolutions and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Pacira BioSciences,.
Diversification Opportunities for Emergent Biosolutions and Pacira BioSciences,
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Emergent and Pacira is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Pacira BioSciences, go up and down completely randomly.
Pair Corralation between Emergent Biosolutions and Pacira BioSciences,
Considering the 90-day investment horizon Emergent Biosolutions is expected to under-perform the Pacira BioSciences,. In addition to that, Emergent Biosolutions is 1.46 times more volatile than Pacira BioSciences,. It trades about -0.12 of its total potential returns per unit of risk. Pacira BioSciences, is currently generating about 0.15 per unit of volatility. If you would invest 1,867 in Pacira BioSciences, on December 5, 2024 and sell it today you would earn a total of 486.00 from holding Pacira BioSciences, or generate 26.03% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Emergent Biosolutions vs. Pacira BioSciences,
Performance |
Timeline |
Emergent Biosolutions |
Pacira BioSciences, |
Emergent Biosolutions and Pacira BioSciences, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Emergent Biosolutions and Pacira BioSciences,
The main advantage of trading using opposite Emergent Biosolutions and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Pacira BioSciences, vs. Phibro Animal Health | Pacira BioSciences, vs. Dr Reddys Laboratories | Pacira BioSciences, vs. Collegium Pharmaceutical | Pacira BioSciences, vs. Prestige Brand Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |